JP2007536906A5 - - Google Patents

Download PDF

Info

Publication number
JP2007536906A5
JP2007536906A5 JP2006541888A JP2006541888A JP2007536906A5 JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5 JP 2006541888 A JP2006541888 A JP 2006541888A JP 2006541888 A JP2006541888 A JP 2006541888A JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5
Authority
JP
Japan
Prior art keywords
binding affinity
gag binding
less
fold
help
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007536906A (ja
JP4980721B2 (ja
Filing date
Publication date
Priority claimed from AT0195203A external-priority patent/AT412785B/de
Application filed filed Critical
Publication of JP2007536906A publication Critical patent/JP2007536906A/ja
Publication of JP2007536906A5 publication Critical patent/JP2007536906A5/ja
Application granted granted Critical
Publication of JP4980721B2 publication Critical patent/JP4980721B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541888A 2003-12-04 2004-12-02 Gag結合蛋白質 Expired - Fee Related JP4980721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0195203A AT412785B (de) 2003-12-04 2003-12-04 Gag-bindungsproteine
ATA1952/2003 2003-12-04
PCT/EP2004/013670 WO2005054285A1 (en) 2003-12-04 2004-12-02 Gag binding proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012040123A Division JP2012139226A (ja) 2003-12-04 2012-02-27 Gag結合蛋白質

Publications (3)

Publication Number Publication Date
JP2007536906A JP2007536906A (ja) 2007-12-20
JP2007536906A5 true JP2007536906A5 (cg-RX-API-DMAC10.html) 2012-04-12
JP4980721B2 JP4980721B2 (ja) 2012-07-18

Family

ID=33494536

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006541888A Expired - Fee Related JP4980721B2 (ja) 2003-12-04 2004-12-02 Gag結合蛋白質
JP2012040123A Pending JP2012139226A (ja) 2003-12-04 2012-02-27 Gag結合蛋白質
JP2012086483A Pending JP2012165747A (ja) 2003-12-04 2012-04-05 Gag結合蛋白質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012040123A Pending JP2012139226A (ja) 2003-12-04 2012-02-27 Gag結合蛋白質
JP2012086483A Pending JP2012165747A (ja) 2003-12-04 2012-04-05 Gag結合蛋白質

Country Status (20)

Country Link
US (4) US7585937B2 (cg-RX-API-DMAC10.html)
EP (5) EP2311866A1 (cg-RX-API-DMAC10.html)
JP (3) JP4980721B2 (cg-RX-API-DMAC10.html)
KR (2) KR101188785B1 (cg-RX-API-DMAC10.html)
CN (1) CN1890264B (cg-RX-API-DMAC10.html)
AT (3) AT412785B (cg-RX-API-DMAC10.html)
AU (1) AU2004295104B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0416544A (cg-RX-API-DMAC10.html)
CA (1) CA2546789A1 (cg-RX-API-DMAC10.html)
CY (2) CY1109480T1 (cg-RX-API-DMAC10.html)
DE (1) DE602004022595D1 (cg-RX-API-DMAC10.html)
DK (2) DK1689775T3 (cg-RX-API-DMAC10.html)
ES (2) ES2330362T3 (cg-RX-API-DMAC10.html)
IL (1) IL175565A0 (cg-RX-API-DMAC10.html)
NZ (1) NZ547612A (cg-RX-API-DMAC10.html)
PL (2) PL1752470T3 (cg-RX-API-DMAC10.html)
PT (2) PT1752470E (cg-RX-API-DMAC10.html)
SG (1) SG149000A1 (cg-RX-API-DMAC10.html)
SI (2) SI1752470T1 (cg-RX-API-DMAC10.html)
WO (1) WO2005054285A1 (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
CN100366637C (zh) * 2005-11-17 2008-02-06 中国人民解放军第四军医大学 人白细胞介素8拮抗蛋白及其制备方法
US9422356B2 (en) * 2006-01-31 2016-08-23 Republic Of Korea (Republic Of National Fisheries Research And Development Institute) Artificial signal peptide for expressing an insoluble protein as a soluble active form
JP5173838B2 (ja) 2006-02-13 2013-04-03 アレシア・バイオセラピューティクス・インコーポレーテッド 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
EP1894571A1 (en) * 2006-08-29 2008-03-05 Protaffin Biotechnologie AG Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection
US20100075918A1 (en) * 2006-12-08 2010-03-25 Lokeshwar Vinata B Hyaluronidase inhibitors as anti-cancer agents
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine
CA2686817A1 (en) * 2007-05-07 2009-02-19 Peptimmune, Inc. Methods for the directed expansion of epitopes for use as antibody ligands
EP2042516A1 (en) * 2007-09-27 2009-04-01 Protaffin Biotechnologie AG Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same
EP2185719B1 (en) 2007-08-02 2013-11-13 NovImmune SA Anti-rantes antibodies and methods of use thereof
EP2053060A1 (en) * 2007-10-24 2009-04-29 Protaffin Biotechnologie AG SDF-1-based glyocosaminoglycan antagonists and methods of using same
US8314212B2 (en) * 2008-02-08 2012-11-20 Lindsey Miles Plasminogen receptor PLG-RKT and antibodies thereof
US20120046218A1 (en) 2009-01-30 2012-02-23 Protaffin Biotechnologie Ag Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
WO2011029931A1 (en) 2009-09-11 2011-03-17 Protaffin Biotechnologie Ag Composition for treatment of cxcl8-mediated lung inflammation
CA2928846A1 (en) 2009-11-24 2011-06-03 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
WO2012123585A1 (en) 2011-03-16 2012-09-20 Protaffin Biotechnologie Ag Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same
EP2729487A2 (en) 2011-07-08 2014-05-14 Protaffin Biotechnologie AG Novel sdf-1-based glycosaminoglycan antagonist and methods of using same
CA2862739A1 (en) 2012-02-22 2013-08-29 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
AU2013293062A1 (en) 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
WO2014079957A1 (de) * 2012-11-23 2014-05-30 Bayer Cropscience Ag Selektive inhibition der ethylensignaltransduktion
US9493528B2 (en) * 2013-01-10 2016-11-15 Supadelixir Inc. Microphthalmia-associated transcription factor-derived peptide and composition containing same
WO2015110526A1 (en) * 2014-01-22 2015-07-30 Antagonis Biotherapeutics Gmbh Novel glycosaminoglycan-antagonising fusion proteins and methods of using same
WO2021038033A1 (en) 2019-08-29 2021-03-04 Antagonis Biotherapeutics Gmbh T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity
CN110791523B (zh) * 2019-12-13 2022-05-10 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
WO2023003984A2 (en) * 2021-07-20 2023-01-26 Oregon Health & Science University Label-free detection of protease activity
KR20250040765A (ko) * 2023-09-15 2025-03-25 (주)케어젠 펩타이드를 유효성분으로 하는 발모 촉진 또는 탈모증의 억제, 예방 또는 개선용 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960691A (en) * 1986-09-29 1990-10-02 Abbott Laboratories Chromatographic test strip for determining ligands or receptors
US5234911A (en) * 1990-07-09 1993-08-10 Gist-Brocades, N.V. Substance with interleukin-8 inhibiting activity and process for its preparation
AU8947791A (en) 1990-11-01 1992-05-26 Scripps Research Institute, The Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
EP0607777B1 (de) * 1993-01-08 1998-12-09 Hoechst Aktiengesellschaft Verwendung von Leflunomid zur Hemmung von Interleukin 8
JP2694321B2 (ja) * 1993-03-10 1997-12-24 大塚製薬株式会社 インターロイキン−1阻害剤
US5527546A (en) * 1994-08-10 1996-06-18 Bayer Corporation Human interleukin 6 inhibitor
US5866402A (en) * 1995-05-05 1999-02-02 Chiron Corporation Chimeric MCP and DAF proteins with cell surface localizing domain
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−8産生阻害剤
US6852696B2 (en) * 1999-03-26 2005-02-08 The University Of Texas System Inhibitors of glycosaminoglycans
WO2002020715A2 (en) 2000-09-05 2002-03-14 Biosight Ltd. Peptide conjugated anti-cancer prodrugs
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB0110430D0 (en) * 2001-04-27 2001-06-20 Medical Res Council Protein variants and uses thereof
JP2003063980A (ja) * 2001-08-28 2003-03-05 Noevir Co Ltd Rantes産生阻害剤
US6982170B1 (en) * 2001-12-17 2006-01-03 Maine Medical Center Research Institute Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
JP2003306438A (ja) * 2002-02-18 2003-10-28 Shiseido Co Ltd ケモカイン発現阻害剤
JP2003267887A (ja) * 2002-03-15 2003-09-25 Shiseido Co Ltd ケモカイン発現抑制皮膚外用剤
IL164376A0 (en) * 2002-04-03 2005-12-18 Applied Research Systems Ox4or binding agents, their preparation and pharmaceutical compositions containing them
CN1665839A (zh) * 2002-04-10 2005-09-07 应用研究系统Ars股份公司 Mcp蛋白质的新型拮抗剂
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine

Similar Documents

Publication Publication Date Title
Thompson et al. The ribosomal protein Asc1/RACK1 is required for efficient translation of short mRNAs
Li et al. Surface protein imprinted core–shell particles for high selective lysozyme recognition prepared by reversible addition–fragmentation chain transfer strategy
JP2010529860A5 (cg-RX-API-DMAC10.html)
WO2007067730A3 (en) Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
HUP0105337A2 (hu) Az immunválaszban szerepet játszó új polipeptidek
JP2007508034A5 (cg-RX-API-DMAC10.html)
WO2024138472A1 (zh) 孔蛋白单体、孔蛋白及其突变体和其应用
Natalello et al. Compact conformations of α‐synuclein induced by alcohols and copper
Veglia et al. The structure of the metal-binding motif GMTCAAC is similar in an 18-residue linear peptide and the mercury binding protein MerP
EP2270038A3 (en) GAG binding proteins
Lind et al. Post translational modifications in adenovirus type 2
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
Flood et al. Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus
Ospinal-Jimenez et al. Structural analysis of protein denaturation with alkyl perfluorinated sulfonates
WO2002012290A8 (en) Sid polypeptides binding to pathogenic strain of the hepatitis c virus
Westerhuis et al. Reevaluation of the electrophoretic migration behavior of soluble globular proteins in the native and detergent-denatured states in polyacrylamide gels
Lim et al. The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction
WO2007052102A3 (en) Modified green fluorescent proteins and methods for using same
WO2003060098A3 (en) Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
DK1297110T3 (da) Attenueret bovin respiratorisk syncytialvirus
Jeong et al. Tuning oligovalent biomacromolecular interfaces using double-layered α-helical coiled-coil nanoassemblies from lariat-type building blocks
Kiyokawa et al. Engineering of the hydrophobic core of an α‐helical coiled coil
JP2016505514A5 (cg-RX-API-DMAC10.html)
Agrawal et al. SLAM (CD150) receptor homologous peptides block the peste des petits ruminants virus entry into B95a cells
Ramos et al. Proteomics based on peptide fractionation by SDS-free PAGE